These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32860119)

  • 1. Impact and Management of Dysphagia in Inflammatory Myopathies.
    Zeng R; Schmidt J
    Curr Rheumatol Rep; 2020 Aug; 22(10):74. PubMed ID: 32860119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients.
    Oh TH; Brumfield KA; Hoskin TL; Stolp KA; Murray JA; Bassford JR
    Mayo Clin Proc; 2007 Apr; 82(4):441-7. PubMed ID: 17418072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis.
    Giannini M; Fiorella ML; Tampoia M; Girolamo F; Fornaro M; Amati A; Lia A; Abbracciavento L; D'Abbicco D; Iannone F
    Rheumatology (Oxford); 2021 Mar; 60(3):1234-1242. PubMed ID: 32911543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dysphagia and its severity on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathies other than inclusion body myositis.
    Ohmura SI; Tamechika SY; Miyamoto T; Kunieda K; Naniwa T
    Int J Rheum Dis; 2022 Aug; 25(8):897-909. PubMed ID: 35678075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence.
    Mulcahy KP; Langdon PC; Mastaglia F
    Dysphagia; 2012 Mar; 27(1):64-9. PubMed ID: 21442390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of dysphagia in inclusion body myositis.
    Darrow DH; Hoffman HT; Barnes GJ; Wiley CA
    Arch Otolaryngol Head Neck Surg; 1992 Mar; 118(3):313-7. PubMed ID: 1313247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of swallowing function with oro-pharyngeal-esophageal scintigraphy in patients with idiopathic inflammatory myopathies.
    Barsotti S; Puccini G; Tripoli A; Cardelli C; Minichilli F; Volterrani D; Mosca M; Grosso M; Neri R
    Neurogastroenterol Motil; 2019 Jul; 31(7):e13599. PubMed ID: 31012534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing and managing dysphagia in inclusion body myositis: a systematic review.
    Ambrocio KR; Garand KLF; Roy B; Bhutada AM; Malandraki GA
    Rheumatology (Oxford); 2023 Oct; 62(10):3227-3244. PubMed ID: 37115631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysphagia as the Presenting Symptom for Inclusion Body Myositis.
    Esteban MJ; Kassar D; Padilla O; McCallum R
    J Investig Med High Impact Case Rep; 2021; 9():23247096211050211. PubMed ID: 34886694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the evaluation and management of dysphagia in sporadic inclusion body myositis.
    Garand KLF; Malandraki GA; Dimachkie MM
    Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):362-367. PubMed ID: 37678324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysphagia due to inclusion body myositis: case presentation and review of the literature.
    Ko EH; Rubin AD
    Ann Otol Rhinol Laryngol; 2014 Sep; 123(9):605-8. PubMed ID: 24634148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstruction-related dysphagia in inclusion body myositis: Cricopharyngeal bar on videofluoroscopy indicates risk of aspiration.
    Taira K; Yamamoto T; Mori-Yoshimura M; Fujita S; Oya Y; Nishino I; Takahashi Y
    J Neurol Sci; 2020 Jun; 413():116764. PubMed ID: 32172012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis.
    Schrey A; Airas L; Jokela M; Pulkkinen J
    J Neurol Sci; 2017 Sep; 380():142-147. PubMed ID: 28870555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathies featuring early or prominent dysphagia.
    Triplett JD; Pinto MV; Hosfield EA; Milone M; Liewluck T
    Muscle Nerve; 2020 Sep; 62(3):344-350. PubMed ID: 32510670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors, outcome and characteristics of oropharyngeal dysphagia in idiopathic inflammatory myopathy.
    Labeit B; Perlova K; Pawlitzki M; Ruck T; Muhle P; Claus I; Suntrup-Krueger S; Wiendl H; Dziewas R; Warnecke T
    Muscle Nerve; 2021 Jun; 63(6):874-880. PubMed ID: 33711182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysphagia in patients with inclusion body myositis.
    Houser SM; Calabrese LH; Strome M
    Laryngoscope; 1998 Jul; 108(7):1001-5. PubMed ID: 9665246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cricopharyngeal bar and dermatomyositis: A cause of rapidly progressive dysphagia.
    Adams CL; Lohan S; Bruce A; Kamalaraj N; Gunaratne S; White R
    Int J Rheum Dis; 2021 Jan; 24(1):125-131. PubMed ID: 33135370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis.
    Liu LW; Tarnopolsky M; Armstrong D
    Can J Gastroenterol; 2004 Jun; 18(6):397-9. PubMed ID: 15190396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis.
    Salam S; Allen J; Dimachkie MM; Hanna MG; Machado PM
    Clin Exp Rheumatol; 2024 Feb; 42(2):425-435. PubMed ID: 38372730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of anti-NT5c1A autoantibody in Korean patients with inflammatory myopathies.
    Lee SA; Lee HJ; Suh BC; Shin HY; Kim SW; Yoon BA; Choi YC; Park HJ
    PLoS One; 2023; 18(4):e0284409. PubMed ID: 37058449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.